See today's (or Friday's?) Sydney Morning Herald. Sigma beat them for the Pharmacy Alliance contract, though it is not binding on Pharmacy Alliance members and some will stay with API. It is a setback. Combined with the Pfizer decision to distribute direct, API is in a "bad news" phase. I sold some but am holding and will buy more if they get cheaper.